Clinical trials of a pioneering new cancer therapy known as AUTO3, developed by UCL spinout company Autolus Therapeutics, have shown positive initial results.
Paediatric researchers from across the UK came together for a special training weekend hosted by the NIHR GOSH Biomedical Research Centre (BRC) earlier this month.
Great Ormond Street Hospital (GOSH) is to become the first hospital in the UK to offer a pioneering cancer therapy, known as CAR-T therapy, to NHS patients with B-cell acute lymphoblastic leukaemia (ALL). The first patients begin treatment at GOSH this we
Orchard Therapeutics, has launched is initial public offering (IPO) on the Nasdaq stock exchange. The company, which specialises in developing gene therapies for complex rare diseases, sold 14.3 million shares to raise $225 million of investment.
A team from Great Ormond Street Hospital (GOSH) and University College London Hospitals (UCLH) have carried out the first two operations on the damaged spinal cords of babies in the womb, in what are the first surgeries of their kind in the UK.